The compound of Formula 1 is a novel piperazinylalkylpyrazole derivative, which particulary has T-type Ca2+ channel blocking effect and thus can be useful as a therapeutic agent for nerve and muscle pain."/>
公开/公告号US2007049604A1
专利类型
公开/公告日2007-03-01
原文格式PDF
申请/专利号US20060509769
申请日2006-08-25
分类号A61K31/496;C07D403/02;
国家 US
入库时间 2022-08-21 21:02:53